Product Code: ETC044705 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Companion animal specialty drugs are products specifically designed to treat and manage diseases in companion animals such as cats, dogs, birds, rabbits and horses. These medicines have a high degree of effectiveness in treating these illnesses but are often very expensive. In Thailand the market for companion animal specialty drugs is expected to grow significantly over the forecast period from 2020-2026 due to increasing pet ownership and growing awareness about specialized care for pets.
The primary driver behind the growth of this market is increased pet ownership among people living in urban areas. This has led to more demand for veterinary services which include prescribing specialty drugs for treatment of various ailments related to pets such as cancer, infection etc. Additionally, rising disposable incomes amongst consumers also driving sales of Companion Animal Specialty Drugs in Thailand. Growing awareness regarding preventive healthcare measures taken by veterinarians will further accelerate growth prospects during the forecast period (2020-2026).
Despite strong potential and opportunities existing within Thailand Companion Animal Specialty Drug Market there exist certain challenges that may restrain its growth rate over medium term outlook. Firstly cost associated with these medications can be quite expensive when compared with traditional medications thus making it difficult for majority population to afford them resulting into slower adoption rate across rural regions where individuals don???t have access or knowledge about same leading towards lower sales numbers & revenue generation opportunities during 2020-26 timeframe.Besides this availability issues might arise due conflicts between manufacturers & distributors resulting into supply side pressures affecting overall industry profitability margins over short term duration.
COVID -19 pandemic had huge impact on global economy including Thailand speciality drug sector, Several manufacturing operations were temporarily halted during initial days resulting into delayed shipments & low consumer confidence levels dampening overall sale volume trends.Despite efforts undertaken by govt authorities & producers alike situation remains uncertain till date however gradual recovery gaze being witnessed post second quarter owing considerable increase export activities from country.Also E commerce retailing aided via digital marketing campaigns helped bolster online revenues while supporting sector revival process going forward
Major players operating within Thailand Companion Animal Specialty Drugs Market includes Elanco India Ltd., Merial Inc., Bayer AG, Zoetis Inc., Virbac India Pvt Ltd., Boehringer Ingelheim GmbH, Vetoquinol SAetc
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Companion Animal Specialty Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, 2020 & 2030F |
3.3 Thailand Companion Animal Specialty Drugs Market - Industry Life Cycle |
3.4 Thailand Companion Animal Specialty Drugs Market - Porter's Five Forces |
3.5 Thailand Companion Animal Specialty Drugs Market Revenues & Volume Share, By Product Types, 2020 & 2030F |
3.6 Thailand Companion Animal Specialty Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F |
4 Thailand Companion Animal Specialty Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Companion Animal Specialty Drugs Market Trends |
6 Thailand Companion Animal Specialty Drugs Market, By Types |
6.1 Thailand Companion Animal Specialty Drugs Market, By Product Types |
6.1.1 Overview and Analysis |
6.1.2 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Product Types, 2020-2030F |
6.1.3 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Anti-Inflammatory Drugs, 2020-2030F |
6.1.4 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Vaccines, 2020-2030F |
6.1.5 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Antibiotics, 2020-2030F |
6.1.6 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Animal Feed Additives, 2020-2030F |
6.1.7 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Parasiticides, 2020-2030F |
6.1.8 Thailand Companion Animal Specialty Drugs Market Revenues & Volume, By Skin Care Products, 2020-2030F |
6.2 Thailand Companion Animal Specialty Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
7 Thailand Companion Animal Specialty Drugs Market Import-Export Trade Statistics |
7.1 Thailand Companion Animal Specialty Drugs Market Export to Major Countries |
7.2 Thailand Companion Animal Specialty Drugs Market Imports from Major Countries |
8 Thailand Companion Animal Specialty Drugs Market Key Performance Indicators |
9 Thailand Companion Animal Specialty Drugs Market - Opportunity Assessment |
9.1 Thailand Companion Animal Specialty Drugs Market Opportunity Assessment, By Product Types, 2020 & 2030F |
9.2 Thailand Companion Animal Specialty Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F |
10 Thailand Companion Animal Specialty Drugs Market - Competitive Landscape |
10.1 Thailand Companion Animal Specialty Drugs Market Revenue Share, By Companies, 2023 |
10.2 Thailand Companion Animal Specialty Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |